title: [Plasma serine protease inhibitors in patients with liver cirrhosis].
abstract: In 28 patients with liver cirrhosis as compared with the control group decreased concentrations of alpha 2-antiplasmin, antithrombin III and activator plasminogen inhibitor were observed. Decrease of these inhibitors was lower in advanced stages of cirrhosis accompanied by hypoalbuminemia and hyperbilirubinemia.
authors.affiliation: Katedra i Zakład Patofizjologii A.M. w Bydoszczy.
authors.forename: M
authors.initials: M
authors.lastname: Piatkowska
authors.forename: M
authors.initials: M
authors.lastname: Kotschy
authors.forename: D
authors.initials: D
authors.lastname: Rość
authors.forename: E
authors.initials: E
authors.lastname: Wiśniewska
authors.forename: J
authors.initials: J
authors.lastname: Opoka
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood*; D008297:Male; D008875:Middle Aged; D015842:Serine Proteinase Inhibitors / Q000097:blood*
chemical_list: D015842:Serine Proteinase Inhibitors
vernacular_title: Osoczowe inhibitory proteaz serynowych u chorych na marskość watroby.